A prospective, open-label treatment trial to compare the effect of IFN b-1a (Avonex), IFNb-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

CLICK HERE TO DOWNLOAD THE PDF

 

Publication Date: November 2005 /
Author: A. C. Tselis / J. A. Kamholz / J. Y. Garbern / O. A. Khana / R. A. Lewis / R. P. Lisak /
Categories: Drugs / Journal Articles / Specific to MS /

2018-01-17T17:04:28+00:00
MAKE A DONATION